Dosimetric impact of interfraction prostate and seminal vesicle volume changes and rotation: A post-hoc analysis of a phase III randomized trial of MRI-guided versus CT-guided stereotactic body radiotherapyTing Martin, Amar U. Kishan, James Lamb et al.|Radiotherapy and Oncology|2021Cited by 43
Magnetic resonance imaging-guided versus computed tomography-guided stereotactic body radiotherapy for prostate cancer (MIRAGE): Interim analysis of a phase III randomized trial.Amar U. Kishan, Michael L. Steinberg, James Lamb et al.|Journal of Clinical Oncology|2022Cited by 30
One Year Radiographic Response Following Prostrate SBRT: An Exploratory Analysis of a Phase III Randomized TrialTommy Jiang, Amar U. Kishan, Luca Valle et al.|International Journal of Radiation Oncology*Biology*Physics|2023Cited by 0
Impact of Organ-at-Risk (OAR) Radiation Dosimetry on Acute and Late Toxicity after Prostate Stereotactic Body Radiation Therapy (SBRT): A Post-Hoc Analysis of a Phase III Randomized Clinical Trial of MRI-Guided vs. CT-Guided SBRTBeth K. Neilsen, Amar U. Kishan, T. Jiang et al.|International Journal of Radiation Oncology*Biology*Physics|2024Cited by 0